FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2117307674> ?p ?o ?g. }

• W2117307674 endingPage "429" @default.
• W2117307674 startingPage "420" @default.
• W2117307674 abstract "Each of the embolic protection devices used in carotid artery stenting (CAS) has advantages and disadvantages. The prospective, multicenter, single-arm EMPiRE Clinical Study investigated a proximally placed device (GORE Flow Reversal System) that provides distal neuroprotection during CAS by reversing blood flow in the internal carotid artery, thereby directing emboli away from the brain.The study evaluated 30-day outcomes in 245 pivotal high-surgical-risk patients (mean age, 70 years; 32% symptomatic; 16% ≥80-years old) with carotid stenosis who underwent CAS using the flow reversal system. The primary endpoint was a major adverse event (MAE; stroke, death, myocardial infarction, or transient ischemic attack) within 30 days of CAS. The MAE rate was compared with an objective performance criterion (OPC) derived from CAS studies that included embolic protection.The MAE rate was 4.5% (11 patients; P=0.002 compared with the OPC). The stroke and death rate was 2.9%. No patient had a major ischemic stroke. Six patients (2.4%) had intolerance to flow reversal. The death and stroke rates in the symptomatic, asymptomatic, and octogenarian subgroups were 2.6, 3, and 2.6%, respectively, meeting American Heart Association guidelines for carotid endarterectomy.The stroke and death rate in this study was among the lowest in CAS trials. The results indicate that the flow reversal system is safe and effective when used for neuroprotection during CAS and that it provides benefits in a broad patient population." @default.
• W2117307674 created "2016-06-24" @default.
• W2117307674 creator A5020646272 @default.
• W2117307674 creator A5028014140 @default.
• W2117307674 creator A5032204536 @default.
• W2117307674 creator A5045922184 @default.
• W2117307674 creator A5048566091 @default.
• W2117307674 creator A5056335297 @default.
• W2117307674 creator A5059898426 @default.
• W2117307674 creator A5081478844 @default.
• W2117307674 creator A5081890576 @default.
• W2117307674 creator A5083044150 @default.
• W2117307674 date "2010-11-03" @default.
• W2117307674 modified "2023-10-08" @default.
• W2117307674 title "Neuroprotection during carotid artery stenting using the GORE flow reversal system: 30-day outcomes in the EMPiRE Clinical Study" @default.
• W2117307674 cites W1435001598 @default.
• W2117307674 cites W1557604963 @default.
• W2117307674 cites W1963920149 @default.
• W2117307674 cites W1965652425 @default.
• W2117307674 cites W1965981448 @default.
• W2117307674 cites W1966892728 @default.
• W2117307674 cites W1972108125 @default.
• W2117307674 cites W1979128772 @default.
• W2117307674 cites W1981086576 @default.
• W2117307674 cites W1987532391 @default.
• W2117307674 cites W1997587060 @default.
• W2117307674 cites W2004558699 @default.
• W2117307674 cites W2014227024 @default.
• W2117307674 cites W2016335167 @default.
• W2117307674 cites W2018438542 @default.
• W2117307674 cites W2022119198 @default.
• W2117307674 cites W2030797448 @default.
• W2117307674 cites W2036301547 @default.
• W2117307674 cites W2038169486 @default.
• W2117307674 cites W2044044877 @default.
• W2117307674 cites W2045050500 @default.
• W2117307674 cites W2056686693 @default.
• W2117307674 cites W2058759171 @default.
• W2117307674 cites W2064100614 @default.
• W2117307674 cites W2083887066 @default.
• W2117307674 cites W2086710926 @default.
• W2117307674 cites W2092530841 @default.
• W2117307674 cites W2097349400 @default.
• W2117307674 cites W2098695855 @default.
• W2117307674 cites W2100140652 @default.
• W2117307674 cites W2101805174 @default.
• W2117307674 cites W2109427114 @default.
• W2117307674 cites W2123898975 @default.
• W2117307674 cites W2128040526 @default.
• W2117307674 cites W2134842939 @default.
• W2117307674 cites W2137169015 @default.
• W2117307674 cites W2141564334 @default.
• W2117307674 cites W2147035197 @default.
• W2117307674 cites W2147226730 @default.
• W2117307674 cites W2169727130 @default.
• W2117307674 cites W2767911074 @default.
• W2117307674 doi "https://doi.org/10.1002/ccd.22789" @default.
• W2117307674 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20853365" @default.
• W2117307674 hasPublicationYear "2010" @default.
• W2117307674 type Work @default.
• W2117307674 sameAs 2117307674 @default.
• W2117307674 citedByCount "111" @default.
• W2117307674 countsByYear W21173076742012 @default.
• W2117307674 countsByYear W21173076742013 @default.
• W2117307674 countsByYear W21173076742014 @default.
• W2117307674 countsByYear W21173076742015 @default.
• W2117307674 countsByYear W21173076742016 @default.
• W2117307674 countsByYear W21173076742017 @default.
• W2117307674 countsByYear W21173076742018 @default.
• W2117307674 countsByYear W21173076742019 @default.
• W2117307674 countsByYear W21173076742020 @default.
• W2117307674 countsByYear W21173076742021 @default.
• W2117307674 countsByYear W21173076742022 @default.
• W2117307674 countsByYear W21173076742023 @default.
• W2117307674 crossrefType "journal-article" @default.
• W2117307674 hasAuthorship W2117307674A5020646272 @default.
• W2117307674 hasAuthorship W2117307674A5028014140 @default.
• W2117307674 hasAuthorship W2117307674A5032204536 @default.
• W2117307674 hasAuthorship W2117307674A5045922184 @default.
• W2117307674 hasAuthorship W2117307674A5048566091 @default.
• W2117307674 hasAuthorship W2117307674A5056335297 @default.
• W2117307674 hasAuthorship W2117307674A5059898426 @default.
• W2117307674 hasAuthorship W2117307674A5081478844 @default.
• W2117307674 hasAuthorship W2117307674A5081890576 @default.
• W2117307674 hasAuthorship W2117307674A5083044150 @default.
• W2117307674 hasConcept C126322002 @default.
• W2117307674 hasConcept C127413603 @default.
• W2117307674 hasConcept C141071460 @default.
• W2117307674 hasConcept C164705383 @default.
• W2117307674 hasConcept C191616109 @default.
• W2117307674 hasConcept C203092338 @default.
• W2117307674 hasConcept C2777910003 @default.
• W2117307674 hasConcept C2779169563 @default.
• W2117307674 hasConcept C2780007028 @default.
• W2117307674 hasConcept C2780645631 @default.
• W2117307674 hasConcept C2781068581 @default.
• W2117307674 hasConcept C2908647359 @default.
• W2117307674 hasConcept C500558357 @default.

• next